What we found on the web about Xolair
Omalizumab (trade name Xolair, Genentech / Novartis) is a humanized antibody drug approved for patients with moderate-to-severe or severe allergic asthma, which is caused by ...
2003 - Xolair (omalizumab) - Subcutaneous injection for moderate to severe persistent asthma. 2003 - Raptiva (efalizumab) - Antibody designed to block the activation and reactivation ...
Now Enrolling. An observational Pregnancy Registry is under way to evaluate pregnancy outcomes in women who have received XOLAIR prior to conception or at any time during pregnancy ...
What is Xolair (Omalizumab)? Omalizumab is an antibody that helps decrease allergic responses in the body. Omalizumab is used to treat moderate to severe asthma that is caused by ...
Xo·lair (z lâr) A trademark for the drug omalizumab. Xolair, a trademark for omalizumab. omalizumab. Xolair. Pharmacologic class: Recombinant DNA-derived immunoglobulin G ...
Omalizumab (trade name Xolair, Genentech / Novartis) is a humanized antibody drug approved for patients with moderate-to-severe or severe allergic asthma, which is caused by ...
The makers of the asthma drug Xolair were ordered in February 2007 to add a black box warning to the label, alerting doctors and patients of the serious side effects associated ...
The asthma drug Xolair has a new ... July 3, 2007 -- The asthma drug Xolair has a new "black box" warning about severe, potentially life-threatening allergic reaction (anaphylaxis ...
If you or a loved one have been administered Xolair and experienced anaphylaxis, a life threatening allergic reaction you may be entitled to compensation. Please fill out the form ...
Xolair ® (Omalizumab) for Subcutaneous Use—Genentech, Inc. July 2008 XOLAIR ® Omalizumab For Subcutaneous Use WARNING Anaphylaxis, presenting as bronchospasm, hypotension ...
Xolair is a relatively new injectable medication used to treat moderate to severe asthma. It is the only medication that acts to block allergic antibody, or IgE, which is the ...
Xolair is a prescription drug that is approved to prevent allergic asthma. This eMedTV page explains how the Xolair injection works to prevent asthma attacks due to certain ...
Xolair, New York Dangerous Drug Lawyer, Class Action Attorneys, Anti-Asthma Medication, Allergic Reaction, Wrongful Death Claims, Side Effect, Anaphylaxis, Blood Pressure Drop ...
Here is what users have to say about Xolair

Omalizumab (trade name Xolair, Genentech / Novartis) is a humanized antibody drug approved for patients with moderate-to-severe or severe allergic asthma, which is caused by hypersensitivity reactions to certain harmless environmental substances. Omalizumab's cost is high ($10,000 to $30,000 per year), as compared to other drugs used for asthma, and hence omalizumab is mainly prescribed for patients with severe, persistent asthma, which cannot be controlled even with high doses of corticosteroids. Like other protein and antibody drugs, omalizumab causes anaphylaxis (a life-threatening systemic allergic reaction) in 1 to 2 patients per 1,000.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!